MIR1294: A Drug Target / Disease Biomarker (G100302181)
MIR1294: A Drug Target / Disease Biomarker
MIR1294, also known as interleukin-12 (IL-12), is a protein that is expressed in various tissues throughout the body, including the immune system, skin, and gastrointestinal tract. It is a key regulator of immune responses and has been implicated in a number of diseases, including cancer, autoimmune disorders, and skin diseases.
One of the key functions of MIR1294 is its role in the regulation of T cell development and function. T cells are a crucial part of the immune system, as they are responsible for recognizing and responding to foreign substances in the body. MIR1294 plays a key role in the development and regulation of T cells by promoting the production of T cells from stem cells and regulating the functions of existing T cells.
In addition to its role in T cell development, MIR1294 has also been shown to have a number of potential drug targets. For example, MIR1294 has been shown to promote the growth and survival of cancer cells, and has been shown to interact with several molecules that are involved in cell signaling pathways, including the TGF-β pathway.
MIR1294 has also been shown to be involved in the regulation of skin health. For example, MIR1294 has been shown to promote the production of skin repair cells and to regulate the function of hair follicles, which are responsible for producing the hair.
In addition to its role in immune and skin health, MIR1294 has also been implicated in a number of other diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.
Overall, MIR1294 is a protein that has a number of potential drug targets and may be a useful target for the development of new treatments for a variety of diseases. Further research is needed to fully understand the role of MIR1294 in these diseases and to develop effective treatments.
Protein Name: MicroRNA 1294
The "MIR1294 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1294 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR1295A | MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1 | MIR181B2 | MIR181C | MIR181D | MIR182 | MIR1825 | MIR1827 | MIR183 | MIR184 | MIR185 | MIR186 | MIR187 | MIR188 | MIR18A | MIR18B
